Project Specifications
A quick-reference overview of the project's core parameters for slate evaluation.
Budget & Financing
The Seraphim is budgeted within a range that reflects the current market for elevated, high-concept horror — large enough to deliver cinematic production value, disciplined enough to achieve strong returns at modest performance thresholds.
The production anticipates a multi-source capital structure typical of independent features in this budget tier. Potential components include:
Equity Investment — Private investor and production company equity, structured with preferred return and participation in net revenues.
Pre-Sales / Minimum Guarantees — International territory pre-sales via a sales agent, particularly across key European and Asian horror markets.
Tax Incentives — Production will be located to maximize applicable state or international film tax credit programs, potentially offsetting 15–30% of qualifying expenditures.
Soft Money / Gap Financing — Completion bond-supported gap finance available as needed upon confirmed pre-sales.
Why This Budget Tier Works for Horror
Supernatural horror consistently over-performs at the $5M–$15M level. The budget allows for a professional cast and crew, practical and VFX elements, and a wide theatrical P&A push, while remaining well below the threshold where profitability requires blockbuster-scale results. The comparable films detailed in Section 04 demonstrate that this budget tier, when paired with strong IP, a compelling cast, and disciplined marketing, routinely yields 5–9x returns.
Financial Projections & ROI Model
The following scenarios model potential revenue across the primary windows for a theatrically-released R-rated supernatural horror feature. Projections are based on comparable film performance and standard industry revenue-sharing models. All figures are illustrative and subject to final deal terms.
Revenue Windows
| Scenario | Domestic Theatrical | Intl. Theatrical | Streaming/Home | Est. Total Revenue | Net to Producers* |
|---|---|---|---|---|---|
| Upside Strong release, word-of-mouth run |
$40M–$60M | $30M–$50M | $15M–$25M | $85M–$135M | $20M–$40M+ |
| Base Case Solid limited-wide release |
$15M–$30M | $12M–$20M | $8M–$15M | $35M–$65M | $5M–$18M |
| Conservative Platform / niche release |
$5M–$12M | $4M–$8M | $4M–$8M | $13M–$28M | Recoupment + modest upside |
*Net to producers after theatrical distribution fees (~35%), P&A costs, and production budget recoupment. Streaming rights negotiated independently from theatrical deal.
Streaming Value Drivers
SVOD demand for horror content remains among the strongest of any genre. A theatrically-proven R-rated supernatural horror feature with cast social reach (see Cast section) will command competitive licensing fees from major platforms including Netflix, Prime Video, Max, and Shudder. Pre-sale or output deal negotiation is anticipated to begin concurrent with principal photography.
Ancillary Revenue
Additional revenue streams include international television sales, physical media (collector's editions perform well in horror), soundtrack licensing, and franchise/sequel rights — all of which represent meaningful upside beyond the primary theatrical and streaming windows.
Comparable Films
The following films establish the financial and tonal landscape in which The Seraphim competes. Each demonstrates that R-rated supernatural horror, when executed with craft and a compelling premise, delivers exceptional returns at this budget level.
Market Context
Horror is consistently the highest-margin genre in film. In 2025, horror dominated the box office — with titles including Final Destination: Bloodlines, The Conjuring: Last Rites, and The Black Phone 2 collectively generating hundreds of millions globally. Audience appetite for R-rated supernatural horror at the multiplex has never been stronger, and SVOD platforms continue to acquire the genre aggressively for their libraries.
Production Timeline
The following represents the anticipated production and release schedule. All phases are subject to adjustment based on financing close date and distribution deal structure.
Distribution Strategy & Target Markets
The Seraphim is positioned for a theatrical-first release strategy, followed by a premium streaming window. This approach maximizes revenue per window while using theatrical performance as leverage in streaming rights negotiations.
Distributor Positioning
The Seraphim is suited for distributors with experience in elevated genre film — including A24, Neon, Lionsgate, Blumhouse Productions / Universal, Searchlight, and IFC Films. The project's cast social media reach (detailed in the Cast section) provides a meaningful built-in marketing asset that reduces a distributor's audience acquisition costs.
Chain of Title & IP Ownership
The Seraphim is based on original screenplay material. The intellectual property is wholly owned by the production entity. No underlying rights clearances, adaptation rights, or third-party IP licenses are required for production or distribution.
Legal representation for chain of title, deal structuring, and rights management is provided by:
Quisenberry Law PLLC
C. Dale Quisenberry
832-680-5000 | dale@quisenberrylaw.com
Rights Available
The following rights are available for licensing or outright acquisition as part of a distribution or production partnership: Worldwide theatrical, domestic theatrical, international theatrical (by territory), SVOD/AVOD/TVOD, physical media, television (broadcast and cable), sequel and franchise rights, and soundtrack/music rights.
E&O Insurance
Errors & Omissions insurance will be obtained prior to delivery as a standard condition of distribution. Title clearance and copyright registration will be completed as part of pre-production legal preparation.
Crew Attachments
Key below-the-line crew are currently being assembled in conjunction with the financing and pre-production process. Department head attachments — including Director of Photography, Production Designer, and Composer — will be confirmed and announced following the financing close.
Candidates are being evaluated with particular attention to genre experience, visual sensibility aligned with the project's tone, and prior credits in the $5M–$20M budget range. Crew attachment packages will be made available to confirmed financing and distribution partners upon request.
Current Key Attachments
Producer: Daniel Herther — Wonder Peak Media (310-626-2222 | daniel@wonderpeak.media)
Production Company: Houston Creative Media Group, LLC (rob@hcmgfilm.com | 833-845-1095)
Legal Representation: Quisenberry Law PLLC, C. Dale Quisenberry
Cast attachments and social media reach are detailed in full in the Cast & Audience section of this business plan.
Festival Strategy & Awards Positioning
A targeted festival run serves dual purposes: it generates critical credibility and press coverage that amplifies the theatrical campaign, and it creates a competitive acquisition environment among distributors. The festival-to-distribution pipeline has become the standard path for elevated horror, as demonstrated by Hereditary (Sundance → A24), The Night House (Sundance → Searchlight), and Talk to Me (Sundance → A24).
Target Festival Submissions
Awards Positioning
While horror is traditionally underrepresented in major awards categories, elevated supernatural horror has increasingly crossed into awards conversation — with Hereditary earning significant critical year-end recognition and A Quiet Place receiving an Academy Award nomination for Sound. The Seraphim's emphasis on performance, original score, and cinematography positions it for genre awards (Saturn Awards, Fangoria Chainsaw Awards) as well as broader critical recognition that supports theatrical positioning.
Press & Critical Strategy
A focused press strategy targeting major horror and genre publications — including Bloody Disgusting, Dread Central, Fangoria, and Rue Morgue — will run parallel to mainstream entertainment press outreach. Early screener access for key critics will be coordinated through the distribution partner's publicity team.